Jeffery H Moran Selected Research

Jeffery H Moran Research Topics

Disease

5	Biotin deficiency 01/2012 - 11/2010
3	Seizures (Absence Seizure) 01/2018 - 01/2011
2	Substance-Related Disorders (Drug Abuse) 01/2022 - 02/2011
2	Opioid-Related Disorders (Opiate Addiction) 01/2019 - 02/2014
2	Psychotic Disorders (Schizoaffective Disorder) 01/2018 - 01/2011
2	Marijuana Use 01/2018 - 01/2011
2	Hallucinations (Hallucination) 01/2018 - 01/2011
2	Mitochondrial Diseases (Mitochondrial Disease) 03/2004 - 02/2002
1	Vascular Malformations 01/2022
1	Interstitial Lung Diseases (Interstitial Lung Disease) 01/2022
1	Cardiac Sudden Death (Sudden Cardiac Arrest) 01/2022
1	Poisoning 01/2022
1	Heart Arrest (Cardiac Arrest) 01/2022
1	Fibrosis (Cirrhosis) 01/2022
1	Syncope (Fainting) 01/2018
1	Chest Pain (Chest Pains) 01/2018
1	Hypothermia 01/2018
1	Supraventricular Tachycardia 01/2018
1	Stab Wounds (Stab Wound) 11/2013
1	Catalepsy 04/2012
1	Panic Disorder (Panic Attack) 01/2011
1	Hypertension (High Blood Pressure) 01/2011
1	Reperfusion Injury 03/2004
1	Hypoxia (Hypoxemia) 03/2004

Drug/Important Bio-Agent (IBA)

4	CannabinoidsIBA 01/2018 - 01/2011
4	Carnitine (L-Carnitine)FDA LinkGeneric 01/2012 - 12/2010
2	Biomarkers (Surrogate Marker)IBA 01/2022 - 11/2010
2	Dronabinol (THC)FDA LinkGeneric 01/2022 - 01/2018
2	Opioid Analgesics (Opioids)IBA 01/2019 - 02/2014
2	beta-hydroxyisovaleric acid (beta-hydroxy-beta-methylbutyrate)IBA 01/2012 - 11/2011
2	Propionyl-Coenzyme A Carboxylase (Propionyl CoA Carboxylase)IBA 01/2012 - 12/2010
2	Biotin (Vitamin H)FDA Link 01/2012 - 12/2010
2	Indicators and Reagents (Reagents)IBA 03/2011 - 12/2010
2	12,13-epoxy-9-octadecenoic acidIBA 03/2004 - 02/2002
1	Acetaminophen (Paracetamol)FDA LinkGeneric 01/2022
1	Keratin-18 (Keratin 18)IBA 01/2022
1	Bleomycin (Blenoxane)FDA LinkGeneric 01/2022
1	K-18 conjugate (K18)IBA 01/2022
1	Alanine Transaminase (SGPT)IBA 01/2022
1	5F-ADB cannabinoidIBA 01/2022
1	Proteins (Proteins, Gene)FDA Link 01/2022
1	DNA (Deoxyribonucleic Acid)IBA 01/2022
1	Pharmaceutical PreparationsIBA 01/2022
1	Sclerosing Solutions (Sclerosing Agents)IBA 01/2022
1	Glutamate DehydrogenaseIBA 01/2022
1	norbuprenorphineIBA 01/2019
1	Naltrexone (ReVia)FDA LinkGeneric 01/2019
1	Buprenorphine (Subutex)FDA LinkGeneric 01/2019
1	N- (1- amino- 3- methyl- 1- oxobutan- 2- yl)- 1- pentyl- 1H- indazole- 3- carboxamideIBA 01/2018
1	Psychotropic Drugs (Psychoactive Drugs)IBA 01/2018
1	N- (1- phenethylpiperidin- 4- yl)- N- phenylacetamideIBA 02/2014
1	1-(5-fluoropentyl)-3-(1-naphthoyl)indoleIBA 11/2013
1	AvidinIBA 01/2012
1	Leucine (L-Leucine)FDA Link 11/2011
1	CreatinineIBA 03/2011
1	EnzymesIBA 12/2010
1	Ouabain (G Strophanthin)IBA 03/2004
1	Epoxy Compounds (Epoxides)IBA 03/2004
1	Arachidonic Acid (Vitamin F)IBA 03/2004
1	12,13-dihydroxyoctadecenoic acidIBA 03/2004
1	Linoleic Acid (Linoleate)IBA 03/2004
1	Adenosine Triphosphate (ATP)IBA 03/2004
1	AcidsIBA 03/2004
1	OligomycinsIBA 03/2004
1	AlbuminsIBA 02/2002

Therapy/Procedure

1	Sclerotherapy 01/2022
1	Drug Therapy (Chemotherapy) 01/2022
1	Analgesia 04/2012
1	Therapeutics 02/2011